These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 19594486)
21. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Lanas A; Hunt R Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305 [TBL] [Abstract][Full Text] [Related]
23. Nonsteroidal antiinflammatory drug use among patients with GI bleeding. Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205 [TBL] [Abstract][Full Text] [Related]
24. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. van Leen MW; van der Eijk I; Schols JM Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740 [TBL] [Abstract][Full Text] [Related]
25. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users. Abraham NS; Hartman C; Castillo D; Richardson P; Smalley W Am J Gastroenterol; 2008 Feb; 103(2):323-32. PubMed ID: 18289200 [TBL] [Abstract][Full Text] [Related]
27. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL; Huang B; Amer F; Christopoulos NG Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480 [TBL] [Abstract][Full Text] [Related]
28. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions. Greene JM; Winickoff RN Arch Intern Med; 1992 Oct; 152(10):1995-2002. PubMed ID: 1417372 [TBL] [Abstract][Full Text] [Related]
29. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN; Callaghan R; Allen ME; Rowe IF Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [TBL] [Abstract][Full Text] [Related]
30. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors. van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747 [TBL] [Abstract][Full Text] [Related]
31. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
32. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center. Bakowsky VS; Hanly JG J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945 [TBL] [Abstract][Full Text] [Related]
33. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130 [TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary? Laine L Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145 [TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261 [TBL] [Abstract][Full Text] [Related]
36. Strategies to reduce the GI risks of antiplatelet therapy. Scheiman JM Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073 [TBL] [Abstract][Full Text] [Related]
37. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study. Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387 [TBL] [Abstract][Full Text] [Related]
38. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
39. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study. Miller K Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707 [TBL] [Abstract][Full Text] [Related]
40. Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illness. Targownik LE; Thomson PA Can Fam Physician; 2006 Sep; 52(9):1100-5. PubMed ID: 17279220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]